220 related articles for article (PubMed ID: 25408748)
1. Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening. Review.
Geamănu Pancă A; Popa-Cherecheanu A; Marinescu B; Geamănu CD; Voinea LM
J Med Life; 2014 Sep; 7(3):322-6. PubMed ID: 25408748
[TBL] [Abstract][Full Text] [Related]
2. Early onset monocular hydroxychloroquine maculopathy in a systemic lupus erythematosus patient with history of central retinal artery occlusion: a case report.
Ameen Ismail A; Sadek SH; Hatata RM
BMC Ophthalmol; 2022 Nov; 22(1):434. PubMed ID: 36376841
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine-induced hyperpigmentation of the skin and bull's-eye maculopathy in rheumatic patients: a case report and literature review.
Peng JP; Yang XY; Luo F; Yuan XM; Xiong H; Ma WK; Yao XM
Front Immunol; 2024; 15():1383343. PubMed ID: 38660312
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
Aylward JM
J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
[TBL] [Abstract][Full Text] [Related]
5. Early hydroxychloroquine macular toxicity.
Warner AE
Arthritis Rheum; 2001 Aug; 44(8):1959-61. PubMed ID: 11508449
[TBL] [Abstract][Full Text] [Related]
6. [Chloroquine retinopathy].
Nguyen AL; Tan AN; Lavrijsen APM
Ned Tijdschr Geneeskd; 2018 Dec; 163():. PubMed ID: 30570930
[TBL] [Abstract][Full Text] [Related]
7. Progression of hydroxychloroquine retinopathy after discontinuation of therapy: case report.
Wei LC; Chen SN; Ho CL; Kuo YH; Ho JD
Chang Gung Med J; 2001 May; 24(5):329-34. PubMed ID: 11480331
[TBL] [Abstract][Full Text] [Related]
8. Extreme Interocular Asymmetry in an Atypical Case of a Hydroxychloroquine-Related Retinopathy.
Hallali G; Seyed Z; Maillard AV; Drine K; Lamour L; Faure C; Audo I
Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888686
[No Abstract] [Full Text] [Related]
9. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
[TBL] [Abstract][Full Text] [Related]
10. A possible early sign of hydroxychloroquine macular toxicity.
Brandao LM; Palmowski-Wolfe AM
Doc Ophthalmol; 2016 Feb; 132(1):75-81. PubMed ID: 26792426
[TBL] [Abstract][Full Text] [Related]
11. Bull's-Eye Maculopathy Associated with Hydroxychloroquine.
Modi YS; Singh RP
N Engl J Med; 2019 Apr; 380(17):1656. PubMed ID: 31018071
[No Abstract] [Full Text] [Related]
12. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
[TBL] [Abstract][Full Text] [Related]
13. Current practices for monitoring ocular toxicity related to hydroxychloroquine (Plaquenil) therapy.
Mazzuca SA; Yung R; Brandt KD; Yee RD; Katz BP
J Rheumatol; 1994 Jan; 21(1):59-63. PubMed ID: 8151589
[TBL] [Abstract][Full Text] [Related]
14. Implementation of recommendations for the screening of hydroxychloroquine retinopathy: poor adherence of rheumatologists and ophthalmologists.
Shulman S; Wollman J; Brikman S; Padova H; Elkayam O; Paran D
Lupus; 2017 Mar; 26(3):277-281. PubMed ID: 27440459
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine Causes Early Inner Retinal Toxicity and Affects Autophagosome-Lysosomal Pathway and Sphingolipid Metabolism in the Retina.
Mondal K; Porter H; Cole J; Pandya HK; Basu SK; Khanam S; Chiu CY; Shah V; Stephenson DJ; Chalfant CE; Mandal N
Mol Neurobiol; 2022 Jun; 59(6):3873-3887. PubMed ID: 35426574
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Fundus Autofluorescence in Systemic Chloroquine/Hydroxychloroquine Therapy.
Reichel C; Berlin A; Radun V; Tarau IS; Hillenkamp J; Kleefeldt N; Sloan KR; Ach T
Transl Vis Sci Technol; 2020 Aug; 9(9):42. PubMed ID: 32934892
[TBL] [Abstract][Full Text] [Related]
17. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
Wolfe F; Marmor MF
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):775-84. PubMed ID: 20535788
[TBL] [Abstract][Full Text] [Related]
18. Hydroxychloroquine retinopathy.
Yusuf IH; Sharma S; Luqmani R; Downes SM
Eye (Lond); 2017 Jun; 31(6):828-845. PubMed ID: 28282061
[TBL] [Abstract][Full Text] [Related]
19. Chloroquine-induced bull's eye maculopathy in rheumatoid arthritis: related to disease duration?
Shinjo SK; Maia OO; Tizziani VA; Morita C; Kochen JA; Takahashi WY; Laurindo IM
Clin Rheumatol; 2007 Aug; 26(8):1248-53. PubMed ID: 17264974
[TBL] [Abstract][Full Text] [Related]
20. Using multifocal ERG ring ratios to detect and follow Plaquenil retinal toxicity: a review : Review of mfERG ring ratios in Plaquenil toxicity.
Lyons JS; Severns ML
Doc Ophthalmol; 2009 Feb; 118(1):29-36. PubMed ID: 18465156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
